Business Wire

Executives from Le Vision Pictures and Le Vision Entertainment to Take the Keynote Stage at CES Asia 2017

Del

The Consumer Technology Association (CTA)™ today announced that Mr. Zhang Zhao, chairman and CEO of Le Vision Pictures and vice chairman of Le Holdings, and Mr. Adam Goodman, president of Le Vision Entertainment, will participate in an entertainment keynote discussion at the upcoming CES Asia™ 2017 in Shanghai, China. The keynote is scheduled for 1:30 PM on Thursday, June 8, in the Kerry Hotel, Level 3, Grand Shanghai Ballrooms 2-3. Owned and produced by CTA and co-produced by Shanghai Intex Exhibition Co., Ltd. (Shanghai Intex), CES Asia 2017 will take place June 7-9 in Shanghai, China.

Mr. Zhang and Mr. Goodman will discuss Le Vision Pictures, a division of Le Holdings, and the opportunities created through the intersection of entertainment and technology. Le Holdings is committed to being a new type of technology company where devices and content are merged through one seamless experience. In this moderated discussion, the two executives will share their experiences, insights and strategies around the business of film and media as well as the overall state of the global technology industry.

“Le Vision Pictures and Le Holdings are bringing disruptive technologies to the emerging Chinese film industry and driving innovation through content and entertainment,” said Gary Shapiro, president and CEO, Consumer Technology Association. “We look forward to hearing Mr. Zhang and Mr. Goodman’s unique perspective into the future of filmmaking in China and globally as they speak before the CES Asia keynote audience.”

Zhang Zhao has had a long career in the Chinese film industry and founded two of China’s biggest private-sector studios. Mr. Zhang graduated from Shanghai’s Fudan University with a Bachelor of Science degree and a Master of Philosophy degree. He also studied film in the United States. After his return to China, Zhang Zhao joined Shanghai Film Group, where he oversaw co-production. In 2006, he founded Enlight Pictures and served as president. In 2011, he started Le Vision Pictures, becoming chairman and CEO. Since then, Le Vision Pictures has distributed over 50 films, grossing more than 100 million yuan. In 2015, he was recognized as an influential leader in the Sino-US film industry. Last year, Zhang Zhao was named one of the Top 10 China Power Players in Entertainment by The Hollywood Reporter.

Adam Goodman is president of Le Vision Entertainment and previously served as president of Paramount Pictures’ Motion Picture Group and Steven Spielberg’s DreamWorks Studios. During his time at Paramount, Mr. Goodman helped develop global film franchises including Transformers, Mission Impossible and Star Trek. Adam also spearheaded Paramount’s successful micro-budget division, Insurge Pictures. Under his leadership, both DreamWorks and Paramount enjoyed their highest grossing years ever in 2007 and 2011. Mr. Goodman joined Le Vision Entertainment following its acquisition of his Dichotomy Micro Studios. Le Vision Entertainment finances feature length projects across genres and distributes across a wide range of platforms from large-scale global firms to innovative micro-budget pictures.

Some 450 companies are exhibiting at the upcoming CES Asia including 3M, Audio-Technica, Baidu, BMW, BYD, Carl Zeiss, Changhong Electric, China Mobile, Continental, Digital China, DJI, Dynaudio, Fossil/Misfit, Garmin, Gibson Brands, Goertek, Haier, Harman, Hisense, Honda, Huawei, Hyundai, JD.com, Konka Group, Mercedes-Benz, Monster, NavInfo, NEVS, Onkyo, OnStar, OtterBox, Pioneer, PPTV, Samsung, Scosche, Segway, Suning, Tencent, United States Postal Service, UPS, Valeo, Volvo, Voxx, Wacom and Yuneec. Ultimately, CES Asia 2017 is expected to draw more than 30,000 attendees and more than 1,100 global media to cover the latest tech innovation across 19 product categories, including major growth areas such as drones, the Internet of Things (IoT) and virtual reality.

See what exhibitors will be showcasing on the CES Asia 2017 show floor in our pitch video playlist. For more information on how to attend or exhibit, visit CESAsia.com. CES Asia industry attendees, media and exhibitors may access the keynotes with a valid show badge.

Note to Editors: Journalists traveling from outside of China will require a J-1 or J-2 visa . For questions about exhibiting at CES Asia, contact Brian Moon at bmoon@CTA.tech or +1 703-907-4351.

About CES Asia:

Owned and produced by the Consumer Technology Association (CTA)TM and co-produced by Shanghai Intex Exhibition Co., Ltd (Shanghai Intex), CES Asia is the premier event for the consumer technology industry, showcasing the full breadth and depth of the innovation value-chain in the Asian marketplace. Key global businesses come to this new event to grow and reinforce their brand by showcasing the latest products and technologies to consumer tech industry executives, foreign buyers, international media and a limited number of consumers from China. Attendees have exclusive access to some of the largest brands from China and around the world, while celebrating the innovation that defines the consumer technology sector.

About Consumer Technology Association:

Consumer Technology Association (CTA) is the trade association representing the $292 billion U.S. consumer technology industry, which supports more than 15 million U.S. jobs. More than 2,200 companies – 80 percent are small businesses and startups; others are among the world’s best known brands – enjoy the benefits of CTA membership including policy advocacy, market research, technical education, industry promotion, standards development and the fostering of business and strategic relationships. CTA also owns and produces CES® – the world’s gathering place for all who thrive on the business of consumer technologies. Profits from CES are reinvested into CTA’s industry services.

About Shanghai Intex:

Shanghai Intex Exhibition Co., Ltd was originally the exhibition organizing business of Shanghai Intex, a pioneering exhibition organizer established in 1995. Shanghai Intex is jointly overseen by the China Council for the Promotion of International Trade (CCPIT) Shanghai and PNO Exhibition Investment (Dubai) Limited. Starting in 1998, Shanghai Intex has organized over 100 trade shows and conferences with a sum total exhibition space in excess of 2 million sqm. Shanghai Intex is comprised of professional teams with a wealth of experience in organizing major international events, covering the creative industry, healthcare, lifestyle, advanced manufacturing and consumer electronics.

UPCOMING EVENTS

  • CES Asia 2017 – Register
    June 7-9, Shanghai, China
  • CEO Summit
    June 21-24, Amalfi Coast, Italy
  • Innovate! and Celebrate
    October 9-11, San Francisco, CA
  • CES Unveiled Amsterdam
    October 26, Amsterdam, Netherlands
  • CES 2018
    January 9-12, Las Vegas, NV

Contact information

Consumer Technology Association
Bernice Morquette, 703-907-7651
bmorquette@CTA.tech
www.CESAsia.com
or
Sarah Brown, 703-907-4326
sbrown@CTA.tech
www.CTA.tech

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Emmaus Life Sciences Announces the New England Journal of Medicine has Published the Phase 3 Trial Results of Endari™ (L-Glutamine Oral Powder) in Sickle Cell Disease18.7.2018 21:45Pressemelding

VIEW E-MEDIA KIT – Emmaus Life Sciences, Inc. (Emmaus) announced today that the New England Journal of Medicine (NEJM) has published the results of its 48-week phase 3 clinical trial of Endari™ (L-glutamine oral powder) which supported the FDA approval in July 2017 to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older. The article reports results that showed significantly fewer sickle cell crises in those receiving Endari compared to placebo by 25 percent; p=0.005 (median 3 vs. median 4) and significantly fewer hospitalizations by 33 percent; p=0.005 (median 2 vs. median 3). Additional findings showed lower cumulative days in hospital of 41 percent; p=0.02 (median 6.5 days vs. median 11 days) and a lower incidence of acute chest syndrome (ACS) by more than 60 percent; p=0.003 (13 of 152 patients [8.6%] had at least 1 ACS compared with 18 of 78 in the placebo group [23.1%]). The most common adverse reactions, occurring in great

Tigo Releases State-of-the-art Wireless Technology – Mesh – as the New Solar Communication Architecture for the TS4 Platform18.7.2018 19:41Pressemelding

Tigo®, pioneer of the smart modular Flex MLPE platform, today announced the release of its new Mesh communication architecture. This state-of-the-art wireless technology directly translates to customer benefits – including simplifying the solar design process and accelerating the commissioning steps. The complete Tigo solution uses a simple yet powerful data collection technology that covers the widest ranges of residential & commercial installations at the lowest cost. With Mesh and the recently announced Tigo Access Point (TAP), customers eliminate the need to address any roof obstruction or orientation constraint. To learn more about Mesh and TAP, register for Tigo’s free, online webinar “The Future of Solar is Wireless” on Wednesday July 25th, 2018 at 10am PDT. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180718005827/en/ Mesh is Tigo's proprietary software that allows each TS4 unit to act as a repeater, extending the

ViiV Healthcare Shares Data from Landmark 2-Drug Regimen Trials At AIDS 201818.7.2018 17:21Pressemelding

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, will be presenting over 20 abstracts, including data from the landmark GEMINI 1 & 2 clinical trials, at the 22nd International AIDS Conference (AIDS 2018), 23-27 July 2018, in Amsterdam, The Netherlands. The data being presented this year has a strong focus on novel exploratory therapeutic options and innovative treatment strategies, as well as improving awareness and understanding of key issues that continue to affect the HIV community. John C Pottage, Jr, MD, Chief Scientific and Medical Officer, ViiV Healthcare, commented, “As we see advancements in the treatment options available to people living with HIV, our research efforts over the past few years have been focused on moving beyond viral load and addressing some of the unresolved issues that people living with HIV face, such as the potential long-term risks and toxicities that can be associated with li

Xilam: H1 2018 Revenue: +50%18.7.2018 16:00Pressemelding

Regulatory News: The Xilam Group (Paris:XIL) posted consolidated H1 2018 revenue of EUR 13,866 thousand, an increase of 50%. This increase represents an excellent performance, as it follows on the heels of growth of 54% in H1 2017. Revenue for the first part of this financial year breaks down as follows. In thousands of euros 30.06.2018 (1) 30.06.2017 Change New productions 8,465 4,571 +85% Catalogue 5,385 4,652 +16% Other 16 16 +0% Revenue and subsidies 13,866 9,239 +50% (1) Unaudited data. Remarkable success for new releases +85% Excellent H1 growth was driven by the two main businesses, New Productions and Catalogue. In New Productions, H1 deliveries generated record revenue of EUR 8,465 thousand, an 85% increase compared with H1 2017, and confirmed Xilam’s position as a major European animation company. Catalogue revenue was up 16% compared with H1 2017, thanks again to traditional TV channels and digital platforms, in both France and abroad. A fast-paced delivery schedule Thanks t

Department for International Trade: Life Sciences at the Heart of UK Economy18.7.2018 12:38Pressemelding

The Government will today (Wednesday 18 July) host the second in a series of roundtables with stakeholders from key life science businesses, demonstrating the importance of the sector to the UK economy. The Chancellor, International Trade Secretary, Business Secretary and Health and Social Care Secretary will be amongst those that meet with senior representatives from leading UK and international life sciences companies as the UK positions itself as the global home of health innovation, welcoming overseas investment and seeking to boost exports in the process. Discussions at the roundtable will focus on how the future of the Life Sciences sector will be supported by the delivery of our modern Industrial Strategy, ensuring that the UK is ‘open for business’ with a positive business environment, our ambitions for a comprehensive agreement with the EU on our future relationship and the development and implementation of our independent trade policy. To date, the government has engaged sign

Universal Laser Systems Expands Its Materials Database with 3M, Victrex and Dexmet Materials18.7.2018 12:05Pressemelding

Universal Laser Systems (ULS) announces the addition of 3M™, Victrex® and Dexmet materials to its materials database, the most extensive repository of laser material processing parameters for materials in the range of 10 watts to 500 watts. The 3M, Victrex and Dexmet materials new to the ULS materials database were specifically added for laser processing with the ULTRA and XLS platforms, suited for high accuracy and precision laser cutting, laser ablation and laser surface modification. The materials include: 3M™ Extreme Sealing Tape 4412N 3M™ Thermally Conductive Silicone Interface Pad 5516 Victrex® APTIV® PEEK Film Dexmet PolyGrid® 8PTFE10-125ST Expanded PTFE Dexmet MicroGrid® AL 25 Expanded Aluminum Laser processing notes, describing the results of the laser-material interaction for these materials, are also available in the Materials Library on the ULS website to help potential customers explore the advantages of deploying laser technology within their manufacturing, research and d